32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
16 °P sammeln
  • Broschiertes Buch

Healthy human life is always cardinal for human being starting from his birth to the end life. Myocardial infarctions produce clinical symptoms that include intense chest pain that may radiate into the neck, jaw or arms, a sense of substernal heaviness, squeezing or pressure, dyspnea, fatigue, syncope, diaphoresis, anxiety, sleeplessness, hypertension or hypotension, tachycardia and arrhythmias. This book includes study of path-physiology, symptoms, complications, diagnostic procedures for myocardial infarction with diagrammatic illustrations. Cilostazol and Milrinone forms the basis of…mehr

Produktbeschreibung
Healthy human life is always cardinal for human being starting from his birth to the end life. Myocardial infarctions produce clinical symptoms that include intense chest pain that may radiate into the neck, jaw or arms, a sense of substernal heaviness, squeezing or pressure, dyspnea, fatigue, syncope, diaphoresis, anxiety, sleeplessness, hypertension or hypotension, tachycardia and arrhythmias. This book includes study of path-physiology, symptoms, complications, diagnostic procedures for myocardial infarction with diagrammatic illustrations. Cilostazol and Milrinone forms the basis of treatment of various heart diseases but this book gives an pre-clinical experimental approach for treating myocardial infarction which is induced by isoproterenol in wistar rats and then subjected to the treatment with cilostazol, milrinone and their combination doses. This book will be of great interest for the cardiologist, physicians, academicians, professors, medical and paramedical students, and will form the basis of authentication for various pre-clinical and clinical studies as these two drugs can be used for treating myocardial infarction within humans.
Autorenporträt
Prashant K. Dhakad, M.Pharm (Pharmacology); Assistant Professor at Galgotias University, India.Professional Experience:Teaching & Research of 5 years.Field of study: Cardioprotective activity.Honors- Editorial Board Member in EJBS, Reviewer in JHRP, Publications in International & National journals,Member of various pharmaceutical organizations